Magnesium 2000 postmarket evaluation: Guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold.

•Magmaris is a sirolimus-eluting bioresorbable magnesium scaffold CE-certified in 2016.•Intraprocedural data of 2000 cases from 356 centers worldwide are presented.•Magmaris was successfully deployed in 99% of cases.•The overall performance was rated as good or very good in 96% of cases.•Dual antiplatelet therapy was predominantly planned for 12 months.